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ABSTRACT
Geographic Biases in Human Lyme disease Surveillance and Utility of Companion Animal
Sentinel Programs: Exploratory Spatial Analysis
Brian Hendricks
Background and Objectives: Mapping and exploratory spatial data analyses are ideal tools for
characterizing spread and occurrence of human Lyme disease infection. Unfortunately, many
mapped displays utilizing Lyme disease surveillance data are prone to bias due to a lack of
consideration for geographical confounders. The objectives of our study were to 1) characterize
the geographic effects that boundary and travel related biases have on visualization of human
Lyme disease occurrence and 2) apply these findings to develop a more precise methodology for
evaluating efficacy of animal sentinel surveillance programs in predicting incidence of human
Lyme disease infection.
Methods: County-level human Lyme disease and companion animal tick surveillance data were
obtained from relevant state health departments. Data were organized within Microsoft Excel
spreadsheets, and sorted by relevant reporting year and county. In Study 1, boundary effects
were evaluated for the region containing Kentucky, Maryland, Ohio, Pennsylvania, Virginia, and
West Virginia 2010-2014, utilizing a combination of rate smoothing and local indicators of
spatial autocorrelation. Trends in disease clustering over time within our multistate region were
evaluated utilizing logistic generalized estimating equations. In Study 2, travel associated biases
were evaluated only for West Virginia confirmed Lyme disease cases 2011-2015, utilizing a
combination of paired t-test, Wilcoxon Rank Signed test, and local indicators of spatial
autocorrelation. In Study 3, the efficacy of the companion animal (dog and cat) sentinel
surveillance program in West Virginia 2014-2016, was evaluated utilizing a combination of
ordinary least squares and spatial regression techniques as well as local indicators of spatial
autocorrelation on regression residuals.
Results: Study 1. Analyses indicated statistically significant (P = 0.05) clustering of human
Lyme disease incidence over time. High-high clusters aggregated near counties bordering high
incidence states, while low-low clusters aggregated near shared county borders in non-high
incidence states. Study 2. Analyses indicated statistical non-equivalency using paired t-test (t =
3.99, df = 54, P = 0.0002) and the non-parametric Wilcoxon Signed Rank test (S=264, P < 0.001)
between total overall cases and those obtained within patient’s home county, suggesting
significant travel-associated bias. Additionally, local indicators of spatial autocorrelation
detected statistically significant (P = 0.05) patterns of clustering in the county level proportion of
cases attributable to travel. Study 3. Regression analyses identified significant associations
between confirmed cases of human Lyme disease and average number of Ixodes scapularis
removed from dogs (ordinary least squares (β=0.20 P < 0.001) and spatial lag (β = 0.12, P =
0.002) models) but not cats for the period 2014-2016. Local indicators of spatial autocorrelation
produced for spatial lag regression residuals indicated a decrease in model over and

underestimation, but identified a higher number of statistically significant outliers than ordinary
least squares regression.
Conclusions: Results of spatial and regression analyses 1) indicate significant differential
clustering of incident human Lyme disease within WV and surrounding states over time; 2)
suggest substantial travel-associated bias in Lyme disease case visualization within WV; and 3)
strongly support the use of companion animal, and specially dog sentinel surveillance programs
for estimation of human Lyme disease risk within WV. These findings suggest that geographic
biases significantly affect visualization of human Lyme disease incidence and support the
effectiveness of utilizing dogs as sentinel populations to estimate human risk. Findings of these
three studies highlight the importance of using statistical methodologies that can accommodate
the spatial structure imbedded within public health surveillance data.
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INTRODUCTION
Lyme disease is the most common vectorborne disease in the United States (1, 2). Transmission
of the etiological agent Borrelia burgderfori to humans is accomplished through the prolonged
attachment of the eastern blacklegged tick Ixodes scapularis, or western blacklegged tick Ixodes
pacificus (3, 4). Clinical diagnosis of Lyme disease within endemic areas is primarily guided by
the manifestation of the EM rash following a seven day incubation period (5). However, up to as
many as 20-30% of patients infected with Lyme disease do not display the characteristic rash
potentially resulting in misdiagnosis (6, 7). If left untreated, patients can develop severe chronic
multisystem conditions with limited treatment options (5, 8).
Cases of human Lyme disease have been reported within every state of the contiguous United
States (9), with two primary disease foci located in the Northeastern and North Central regions
(10). Human case numbers vary dramatically by state, and often display a range of variable
symptoms following infection (11, 12). As a result, criteria were established by Council of State
and Territorial Epidemiologists to collect and analyze clinical, epidemiological, and laboratory
diagnostic evidence within a national human Lyme disease surveillance system. Surveillance
begins when potentially infected patients seek medical attention. Medical providers examine
patients for physical manifestations of Lyme disease, and ask questions relating to exposure to
tick habitat and recent travel history to ascertain probability of exposure (13). Physicians order
diagnostic testing, which involves a screening test (ELISA or IFA), followed by a confirmatory
test (IgG or IgM western blot) using the CDC approved two tier screening approach (13). This
clinical, epidemiologic, and diagnostic evidence is then used to ascertain a case status
(confirmed, probable, suspect, or not a case) to a patient (13).
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Human exposure to Lyme disease is dependent on the overlapping distribution of ticks, hosts and
favorable environmental factors described within the enzootic cycle of Lyme disease (14-16).
Ticks become infected as nymphs or larvae after ingesting blood from reservoir hosts, such as
white footed mice (Peromyscus leucopus). In the traditional enzootic cycle, blacklegged ticks are
infected as larvae and carry the bacteria onto each of their successive life stages (17). The
majority of human cases of Lyme disease are reported in the spring and early summer months
during peak nymphal activity (16). In the fall, adult blacklegged ticks seek large mammalian
hosts such as white tailed deer (Odocoileus virginianus) to locate other ticks for mating and to
consume their final bloodmeal. Humans and other dead end hosts such as dogs, cats, and horses
can also become infected (17, 18) in the fall following attachment of adult blacklegged ticks
(16).
Monitoring of enzootic transmission cycles for Lyme disease is inexact, as human exposure to
infected ticks can vary depending on the climate, host availability, and tick specific diapause
mechanisms (19).Uncertainty regarding the level of human exposure is further compounded by
variability in Lyme disease reporting on a state by state basis (12). Public health researchers have
attempted to pair human and animal Lyme disease surveillance data with exploratory spatial data
analyses (ESDA) to identify high-risk groups and provide a clearer understanding of human risk.
Common ESDA approaches used in public health include disease mapping, cluster analyses, and
ecological analysis (20). Disease mapping applies statistical approaches to remove excess spatial
variation from incidence maps (20-22). Ecological analyses investigate associations between the
geographic distribution of disease incidence and potential explanatory factors (20, 23, 24).
Disease clustering assesses the presence of abnormal aggregations of disease cases within
mapped surveillance data (20, 21, 23). Together these approaches form the foundation of
2

exploratory spatial data analysis (ESDA) and provide a pathway to more complex modelling
approaches (25).
Mapping is one of the most widely used types of graphical displays applied to surveillance data
(23). However generalization of this technique among untrained users often results in inaccurate
interpretation of mapped data (26, 27). Communicating map information in an interpretable and
representative fashion is often complicated by cartographic principles such as scale,
symbolization, and the need for further processing (27, 28). The map’s scale dictates the extent
to which data are averaged across the study area (28). Inappropriate choice of scale can mask or
distort true geographic associations (22, 29). Likewise, in choosing semiotic display in maps,
particular elements of the data are emphasized, while others are obscured or completely
discarded (30). Lack of further processing is a common conceptual problem resulting from
unavailability of data in the form most efficient for interpretation (28). Together these principles
influence perception of mapped surveillance data. For example, incidence of disease is often
displayed within thematic maps containing multiple predefined classes and color schemes.
Audiences are left to their own conclusions regarding the maps overall message depending on
the chosen color scheme and the range of values within the defined classes. These individualistic
interpretations are potentially prone to biases without complementary statistical information (28).
Exploratory spatial analyses have been applied to investigate spatial trends in human and animal
Lyme disease surveillance data. Findings focused on human surveillance data describe potential
clustering and temporal trends in visualization of Lyme disease incidence (10, 31, 32), and
varying model reliability between wild caught ticks and human infection by locality (33). While
previous animal ESDA research explore associations between serosurveys and tick collections
among dogs and human Lyme disease incidence (34-36). Findings indicated that boundary
3

effects and travel-associated infections potentially bias mapped representations of human
incidence (20, 33, 37-39) and that companion animals such as dogs are useful indicators of highrisk for human populations (36, 40). However, studies that adjust for potential geographic biases
in human studies, that incorporate analysis of time trends, and that adjust for spatial dependence
or consider model efficacy in animal surveillance studies remain sparse. Consequently, the
underlying spatial processes influencing the occurrence of human cases and the distribution of
infected ticks and hosts remain obscured, resulting in potentially inaccurate representations of
true human Lyme disease risk.
To accommodate spatial structure within public health Lyme disease surveillance data and fill
current gaps in knowledge, we have developed a series of three complementary studies. The first
study examines human Lyme disease reporting on a regional level and incorporates ESDA rate
smoothing approaches to mitigate boundary effects. Controlling for boundary effects reduces the
influence extreme differences in state level Lyme disease incidence have on accurate
representation of county-level human Lyme disease risk. The second study evaluates travelassociated disease acquisition as a potentially important source of bias in visualization of human
Lyme disease surveillance data in West Virginia and identifies spatial patterns in the proportion
of cases attributable to travel among confirmed human Lyme disease cases. Our final
investigation utilizes ordinary least squares and spatial regression models to identity significant
associations between Ixodes scapularis companion animal collections and human Lyme disease
incidence in West Virginia. We incorporate our research findings from the first two studies by
removing travel-associated cases and adjusting for spatial dependence in county level human
Lyme disease incidence. Additionally we evaluate model efficacy utilizing a combination of
traditional and spatial model selection techniques. Together, these studies address important gaps
4

in current knowledge regarding the visualization of human and animal Lyme disease surveillance
data.

5

LITERATURE CITED
1.
2.
3.
4.

5.
6.
7.
8.
9.
10.
11.
12.

13.

14.
15.
16.
17.

18.
19.
20.

CDC. How Many People Get Lyme Disease. 2015.
(http://www.cdc.gov/lyme/stats/humancases.html). (Accessed 8/11/2016).
Hinckley A, Connally N, Meek J, et al. Lyme Disease Testing by Large Commercial
Laboratories in the United States. Clinical Infectious Diseases 2014;59(5):676-81.
Parola P., Raoult D. Ticks and tickborne bacterial diseases in humans: an emerging
infection threat. Clin Infect Dis 2001;32:897-928.
Estrada-Pena A. JF. Ticks feeding on humans:a review of records on human - biting
Ixodidea with special reference to pathogen transmission. Exp Appl Acarol 1999;23:685715.
Stanek G, Wormser G, Gray J, et al. Lyme borreliosis. The Lancet 2012;379:461-73.
Hayes E, Piesman J. How Can We Prevent Lyme Disease. The New England Journal of
Medicine 2003;348:2424-30.
Bacon R, Kugeler K, Mead P. Surveillance for Lyme Disease --- United States, 1992-2006. MMWR 2008;57(SS10):1-9.
Li J, Hong K, Duan Y, et al. Spatial and Temporal Emergence Pattern of Lyme Disease
in Virginia. American Journal Tropical Medicine and Hygiene 2014;91(6):1166-72.
CDC. Lyme disease data tables. 2015. (http://www.cdc.gov/lyme/stats/tables.html).
(Accessed 8/11/2016).
Kugeler KJ., Farley GM., Forrester JD., et al. Geographic Distribution and Expansion of
Human Lyme Disease, United States. Emerging Infectious Diseases 2015;21(8):1455-57.
Tibbles CD., Edlow JA. Does This PAtient Have Erythema Migrans? JAMA
2007;297(23):2617-27.
Stromdahl E, Hickling G. Beyond Lyme: Etiology of Tick-borne Human Disease with
Emphasis on the South-Eastern United States. Zoonoses and Public Health
2012;59(Suppl 2):48-64.
Centers for Disease Control and Prevention (CDC). Lyme Disease Case Ascertaiment
Criteria. 2017. (https://wwwn.cdc.gov/nndss/conditions/lyme-disease/casedefinition/2017/). (Accessed April 2, 2017).
Ostfeld RS., Glass GE., Keesing F. Spatial epidemiology: an emerging (or re-emerging)
discipline. TRENDS in Ecology and Evolution 2005;20(6):328-36.
Killilea M, Swei A, Lane R, et al. Spatial Dynamics of Lyme Disease: A Review.
EcoHealth 2008;5:167-95.
Mullen GR., Durden LA. Medical and Veterinary Entomology. Burlington, MA:
Academic Press Elsevier; 2009.
Radolf JD, Caimano, M.J., Stevenson, B., Hu, L.T.,. Of ticks, mice and men:
understanding the dual-host lifestyle of Lyme disease spirochaetes [electronic article].
Nat Rev Microbiol.
Little SE., Heise SR., Blagburn BL., et al. Lyme Borreliosis in dogs and humans in the
USA. Trends in Parasitology 2010;26(4):213-8.
Piesman J., Gern L. Lyme borreliosis in Europe and North America. Parasitology
2004;129:S191-S220.
Lawson AB. Statistical Methods in Spatial Epidemiology. Chichester, NY: Wiley & Sons
Ltd.; 2013.
6

21.

22.
23.
24.
25.
26.
27.
28.
29.
30.
31.

32.

33.

34.

35.

36.

37.

38.

Razaeian M., Dunn G., St Leger S., et al. Geographical epidemiology, spatial analysis,
and geographical information systems: a multidisciplinary glossary. Journal of
Epidemiology and Community Health 2007;61(2):98-102.
Elliot P., Wartenburg D. Spatial Epidemiology: Current Approaches and Future
Challenges. Environmental Health Perspectives 2004;112(9):998-1006.
Lawson AB., Biggeri A., Bohning D., et al. Disease Mapping and Risk Assessment For
Public Health. Chichester, NY: John Wiley & Sons Ltd; 1999.
Gatrell AC., Bailey TC. Interactive Spatial Data Analysis in Medical Geography. Soc Sci
Med 1996;42(6):843-55.
Anselin L, Syabri I, Kho Y. GeoDa: An Introduction to Spatial Data Analysis. Geospatial
Analysis 2006;38:5-22.
Jacquez G. Spatial analysis in epidemiology: Nascent science or a failure of GIS? J
Geography Sys 2000;2:91-7.
Slocum TA., McMaster RB., Kessler FC., et al. Thematic Cartography and
Geovisualization. Upper Saddle River, NJ: Pearson Prentice Hall; 2009.
Lawson AB. Statistical Methods in Spatial Epidmiology. West Sussex, England: John
Wiley & Sons Ltd.; 2001.
Lomolino MV., Riddle BR., Whittaker RJ., et al. Biogeography. Sunderland, MA:
Sinauer Associates Inc.; 2010.
Carpendale MST. Considering Visual Variables as a basis for Information Visualization.
University of Calgary: Department of Computer Science; 2003.
Guo L., Sun Z., Di L., et al. Spatial Distribution and variation analysis of Lyme disease in
the Northeastern United States. Agro-Geoinformatics 2016;Fifth International Conference
on IEEE:1-4.
Diuk-Wasser M, Gatewood A, Cislo P, et al. Human Risk of Infection with Borrelia
burgdorferi, the Lyme Disease Agent, in Eastern United States. American Journal of
Tropical Medicine and Hygiene 2012;86(2):320-7.
Pepin KM., Eisen RJ., Mead PS., et al. Geographic Variation in the Relationship between
Human Lyme Disease Incidence and Density of Infected Host Seeking Ixodes scapularis
Nymphs in the Eastern United States. American Journal of Tropical Medicine and
Hygiene 2012;86(6):1062-71.
Glickman LT., Moore GE., Glickman NW., et al. Purdue University-Banfield National
COmpanion Animal Surveillence Program for Emerging and Zoonotic Diseases. VectorBorne and Zoonotic Diseases 2006;6(1):14-23.
Duncan Aw., Correa MT., Levine JF., et al. The Dog as a Sentinel for Human Infection:
Prevalence of Borrelia burgdorferi C6 Antibodies in Dogs from Southeastern and MidAtlantic States. Vector-Borne and Zoonotic Diseases 2005;5(2):101-9.
Smith FD., Ballantyne R., Morgan ER., et al. Estimating Lyme disease risk using pet
dogs as sentinels. Comparative Immunology, Micorbiology, and Infectious Diseases
2012;35:163-7.
Steere AC., Malawista SE. Cases of Lyme Disease in the United States: Location
Correlated with Distribution of Ixodes dammini. Annuals of Internal Medicine
1979;91:730-3.
Hendricks B., Mark-Carew M. using exploratory data analysis to identify and predict
patterns of human Lyme disease case clustering within a multistate region, 2010-2014.
Spatial and Spatio-temporal Epidemiology 2017;20:35-43.
7

39.
40.

Forrester J, Brett M, Matthias J, et al. Epidemiology of Lyme disease in low-incidence
states. Ticks and Tick-borne Diseases 2015;6:721-23.
Hamer SA., Tsao JI., Walker ED., et al. Use of tick surveys and serosurveys to evaluate
pet dogs as a sentinel species for emerging Lyme disease. AJVR 2009;70(1):49-56.

8

CHAPTER ONE
Using Exploratory Data Analysis to Identify and Predict Patterns of Human Lyme Disease
Case Clustering within a Multistate Region, 2010-2014

ABSTRACT
Lyme disease is the most commonly reported vectorborne disease in the United States. The
objective of our study was to identify patterns of Lyme disease reporting after multistate
inclusion to mitigate potential border effects. County-level human Lyme disease surveillance
data were obtained from Kentucky, Maryland, Ohio, Pennsylvania, Virginia, and West Virginia
state health departments. Rate smoothing and Local Moran’s I was performed to identify clusters
of reporting activity and identify spatial outliers. A logistic generalized estimating equation was
performed to identify significant associations in disease clustering over time. Resulting analyses
identified statistically significant (P=0.05) clusters of high reporting activity and trends over
time. High reporting activity aggregated near border counties in high incidence states, while low
reporting aggregated near shared county borders in non-high incidence states. Findings highlight
the need for exploratory surveillance approaches to describe the extent to which state level
reporting affects accurate estimation of Lyme disease progression.
Keywords: Lyme disease; Local Moran’s I; Surveillance
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INTRODUCTION
Lyme disease is the most common vectorborne disease in the United States with an estimated
300,000 new individuals effected annually (1, 2). Acute human infection is typically associated
with one or more erythema migrans (EM) (bull’s eye rash), arthritis, and to a lesser extent Lyme
carditis or neuroborreliosis (3). While early antibiotic therapy is effective in up to 90% of
diagnosed patients (4), approximately 20-30% of patients do not exhibit an EM rash
complicating early diagnosis (5, 6). As a result, many possible human Lyme infections are
misdiagnosed or left untreated, potentially resulting in chronic debilitating multisystem
conditions with limited treatment options (3, 7).
Human Lyme disease infection has been reported from every state in the United States except
Hawaii (8). State level case counts include both locally acquired and travel associated. In recent
years there has been an increasing trend in Lyme disease case reporting; case counts vary by
state, and are thought to be associated with increasing abundance and changing distributions of
tick vectors (9). This increase in the number of human infections paired with changing native
tick populations emphasize the need for sustainable surveillance strategies focused on targeted
prevention and early disease recognition and treatment programs (10).
Exploratory spatial data analysis (ESDA) is one such strategy, allowing analysts the ability to
explore data in terms of space and time. Common ESDA techniques used in public health
include raw and spatial rate smoothing as well as cluster analysis (11-14). Spatial rate smoothing
can be used to increase interpretability of disease maps by adjusting for variations in rate
estimation (7). Cluster analyses are employed to investigate whether disease occurred by random
chance, and understand directionality of disease expansion (7).
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These techniques are ideal Lyme disease surveillance tools because of the inherent spatial
processes that drive human pathogen transmission (15). Infected ticks must be in close spatial
proximity to humans for transmission to occur. Previous studies have employed ESDA to
visualize rates of human Lyme disease and identify pockets of high disease intensity. The
authors found that cases of Lyme disease appeared to cluster near or at state lines, and believed
this to be the result of misdiagnosis, disproportionate presence of infected ticks, or travel
associated infections (7, 13, 14, 16, 17). These possible explanations are supported by previous
work which describe the distribution of Lyme disease between states as dynamic, and
specifically identify travel as potential source for ~80% of cases reported within low incidence
states (9, 18).
The region of the United States that includes the Midwest, Mid-Atlantic, and Southeastern states
of Kentucky, Maryland, Ohio, Pennsylvania, Virginia, and West Virginia is an ideal study area
to characterize Lyme disease case reporting near or at state lines. High incidence states within
the region include Maryland, Pennsylvania, and Virginia, all of which are in the top 15 states that
report Lyme in the nation (19). Alternatively, Kentucky, Ohio, and West Virginia are in the mid
to low range for Lyme disease incidence, but are bordered by one or more of the high incidence
states within our study region (19). To date no known study has described the impact multistate
inclusion has on geographic visualization of Lyme disease incidence within a region, as opposed
to a state by state basis. The objective of our study was to identify patterns of Lyme disease
reporting after multistate inclusion to mitigate potential border effects.
METHODS
Data Acquisition and Management
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County-level probable and confirmed human Lyme disease surveillance data for 2010-2014 were
obtained from the state health departments in West Virginia, Virginia, Ohio, Pennsylvania,
Kentucky, and Maryland. Complete annual case totals were received from all states except for
Kentucky, which had reporting data from 2012-2014. Surveillance data used in our analysis were
limited to confirmed and probable case counts as those are what are nationally reported. Data
were specifically requested from 2010-2014 to incorporate stricter diagnostic criteria within
2008 and 2011 Lyme case definitions (7). Utilizing stricter criteria for case ascertainment led to
increased consistency of medical, laboratory, and epidemiologic evidence among reported cases.
Lyme disease case classification standards at each of the respective state health departments
within the region were based on the current Council of State and Territorial Epidemiologist Case
Definition for Lyme disease (20). A decision diagram is presented in Figure 1.1 to summarize
current Lyme disease case classification criteria (21).
Data were sorted in Microsoft Excel 2010 by state, county, and reporting year. Confirmed and
probable Lyme disease case reports were paired with U.S. census county level population
estimates by year and county (22). Excel spreadsheets containing the county level case
information and population census data were joined within ArcGIS 10.1 (ESRI, Redlands CA) to
a United States Counties and Localities shapefile obtained from U.S. Department of Agriculture
National Resources Conservation Service Geospatial Gateway (USDA: NRCS) (23). The newly
joined features were exported as a shapefiles and analyzed in GeoDa 1.6 (GeoDa Center, Tempe,
AZ).
Descriptive analysis
Crude yearly estimated incidence rates were initially visualized to display variation in raw data.
Estimated incidence by county was calculated by dividing the total number of confirmed and
12

probable Lyme disease cases by the respective county’s yearly July 1rst census estimates. Spatial
weight connectivity histograms were constructed to characterize the distribution of neighbor
structures for rook and queen spatial weights (24). Rook spatial weights characterize polygons
which share a common border as neighbors, while queen spatial weights characterize all
polygons which share a common border or vertex as neighbors. Typically, this difference results
in a stricter neighbor criterion when rook spatial weights are applied. However, distribution of
neighbors among contiguity weights in our study were almost identical, as a result the rook
spatial weight was chosen due to the inconsistent size of counties within the region (13, 25).
Smoothing techniques were applied to adjust crude incidence rates and reduce potential spurious
outliers and biases (16). Adjusted yearly estimated incidence were calculated from the raw data
after applying our rook spatial weight using Spatial Empirical Bayesian techniques to account for
maximum localized instability of Lyme disease reporting rates among neighboring counties (26,
27). Raw and adjusted yearly estimated incidence rates were expressed in terms of cases per
100,000 persons using a quantile classification system with five groupings (0, 4, 20, 60, and >60
cases per 100,000 persons) within ArcGIS 10.1. Incidence rates were classified this way to place
specific emphasis on areas with low to moderate occurrence of Lyme disease.
Cluster Analysis
Local Empirical Bayesian Moran’s I estimates incorporating our previously defined rook spatial
weight were conducted for each year independently by setting yearly annual total case count and
yearly population census estimates as event and base variables respectively. Resulting Moran’s I
scatterplots and local indicators of spatial autocorrelation (LISA) cluster maps with Empirical
Bayesian rates were permuted 99,999 times at a pseudo p-value of 0.05 to optimize sensitivity of
clustering and detection of statistically significant outliers while accounting for instability of
13

population at risk for each year within the region (26, 28, 29). A generalized estimating equation
(GEE) were calculated in SAS 9.4 (SAS Institute Inc., Cary NC) with a logit link, binomial
distribution, and repeated measures statement to describe any significant relationships between
clusters of high reporting activity and time. Our GEE model excluded counties within Ohio and
Kentucky because there were no high-high clusters identified for any of the years within our
study period.
RESULTS
Descriptive analysis
Overall from 2010-2014, 41,922 confirmed and probable Lyme disease cases were reported with
0.25% (n=103) in Kentucky, 17.1% (n=7,186) in Maryland, 0.90% (n=375) in Ohio, 66%
(n=27,591) in Pennsylvania, 14.4% (n=6,031) in Virginia, and 1.52% (n=636) in West Virginia
(Table 1.1). Yearly estimated incidence for states included within the region ranged from 17.123.3 per 100,000 persons. Among non-high incidence states, West Virginia had the highest
estimated incidence of Lyme disease (5.22-7.34 per 100,000 persons), and accounted for only
4.14-4.64% of the regions estimated population. Alternatively, Ohio accounted for 25.8-28.9%
of the regions estimated population, but only had an estimated incidence of 0.38-1.03 per
100,000 persons. Among the region’s high incidence states, Pennsylvania had the highest
estimated incidence of Lyme disease (29.9-58.9 per 100,000 persons) and accounted for the
highest proportion of the regions estimated population (28.5-35.1%). While Maryland accounted
for a lower proportion of individuals in high incidence states than Virginia (13.0-14.5% versus
18.4-20.2%), it had a higher estimated incidence 20.1-28.1 vs 12.6-16.2 per 100,000 persons
respectively.
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County-level Lyme disease incidence per 100,000 persons for each state included within our
study region is displayed in Figure 1.2. Variation in county-level incidence was reduced
following Spatial Empirical Bayesian (SEB) rate, particularly in counties where the population at
risk was smaller (Figure 1.3). Yearly proportion of counties within the region with no reported
cases of Lyme disease decreased from 45-55% to 8-24%. Alternatively, a smaller effect was seen
in counties which reported a yearly incidence of > 60 cases per 100,000 persons (11.7-15.2% vs
11.7-13.8%). Despite this decrease, West Virginia counties of Berkeley, Hampshire, Jefferson,
and Morgan remained the only counties to report an incidence of > 60 cases per 100,000 persons
within a non-high incidence state in our study region.
Cluster analysis
Local Empirical Bayesian Moran’s I estimates of spatial autocorrelation for 2010-2014 were
significant (P =0.05) for each year, and ranged from 0.18 to 0.30. High-high clusters were
identified in Maryland, Pennsylvania, Virginia, and the eastern panhandle of West Virginia
(Figure 1.4). Alternatively, low-low clusters of Lyme reporting were identified in Kentucky,
Ohio, south western Virginia, and West Virginia (Figure 1.4). Spatial outliers (low-high) (n=30)
were identified in Maryland, Pennsylvania, Virginia, and West Virginia during the study period.
Overall, the number of counties regarded as hot spots (high-high) increased over time, while cold
spots (low-low), and statically significant spatial outliers (low-high) fluctuated depending on
year (Figure 1.5). Generalized estimating equations (GEE) were used to assess the trend of
increasing high-high clusters over time from 2010-2014. The fitted model shows that there is a
significant trend (increasing frequency of clusters over time) with OR = 1.29 (P < 0.001). An
exchangeable correlation structure was used in the GEE logistic model.
DISCUSSION
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While spatial analyses have been used for some time in relevant literature, this is one of few
studies to apply spatial analysis on a multistate scale to adjust for reporting activity in
neighboring states. Additionally, this is the first known study to characterize county-level Lyme
case clustering within Kentucky, Ohio, and West Virginia. Among states included, Kentucky had
the lowest number of Lyme disease cases reported (14 to 45), while Pennsylvania had the highest
(3,806 to 7,487). The greatest proportion of the multistate region’s population resided in
Pennsylvania (28.5 to 31.8%), while the smallest proportion resided in West Virginia (4.14 to
4.64%). Incidence rate visualization per 100,000 persons (Figures 1.2-1.3) revealed high
reporting activity in the east and low reporting in the west. Both raw and smoothed rate
visualization highlight the decreasing trend over time for counties with no reported cases of
Lyme disease in the western part of the multistate region, excluding the increase within West
Virginia and Ohio 2011-2012. However, smoothed incidence maps display reduced variability in
county-level reporting among neighboring counties, and displayed fewer counties with no Lyme
disease surveillance data. LISA cluster maps (Figure 1.4) indicated an increasing frequency of
high-high counties observed over time in the eastern part of the multistate region with particular
emphasis in the southwestern corner of Virginia and northeastern panhandle of West Virginia.
This increase over time in high reporting activity within the multistate region is visualized in
Figure 1.5 as the proportion of counties having high-high report clustering over time. Graphical
representation of clustering within the region was displayed as a proportion of the total available
county data due to lack of county level Lyme disease case data for Kentucky, 2010-2011.
Subsequent GEE logistic analysis further supported our findings indicating increasing odds of
county level high-high clustering over our study period within those states which had at least one
high-high cluster identified in the LISA cluster map.
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Study findings are based on a multistate exploratory spatial analysis of county level human Lyme
disease case data. It is important to consider that while ESDA is particularly suited for
identifying patterns of disease, it does not have the ability to explain the observed patterns (13).
Other potential limitations associated with the use of surveillance data are linked to differential
reporting biases which may potentially result in under or over reporting (30). Possible sources of
differential reporting bias are varying presentations of Lyme disease signs and symptoms among
infected patients, varying interpretations of the Lyme disease case definitions and unequal Lyme
disease awareness among physicians and public health professionals (5, 6, 31). We attempt to
adjust for varying interpretations of Lyme case definitions by limiting data acquisition to 20102014, a period in which Lyme case definitions were most similar (20). Unfortunately, there was
no way to control for varying levels of Lyme disease awareness or physician reported Lyme
patient symptoms because of the aggregate and retrospective nature of our investigation.
Despite these potential limitations, public health surveillance data provide valuable information
in regards to Lyme disease occurrence, particularly in areas where pathogen prevalence among
naturally occurring tick populations is rare or largely uncertain (32, 33). National Lyme disease
surveillance data suggest a positive temporal association with cases of disease increasing over
time with two prominent foci in the northeastern and north central United States (33, 34).
Counties within these high incidence foci have continually expanded to now include localities
within Maryland, Pennsylvania, Virginia, and West Virginia (33). This nationally observed trend
is consistent with our study findings as well as studies conducted at the regional and state level,
noting high reporting activity in Pennsylvania and Maryland as well as increasing frequency of
high reporting clusters in Virginia (7, 35).
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In general, epidemiologic patterns of human Lyme disease are largely dependent on tick-host
environmental factors as well as human behaviors such as participation in outdoor activities, pet
ownership, and travel (15, 36, 37). No human behavioral data were collected for any of the cases
analyzed. However, spatial analysis did reveal clusters of high reporting activity near state lines
in Maryland, Pennsylvania, Virginia, and West Virginia. This could suggest that travel history is
important, particularly in non-high incidence states such as West Virginia, where Lyme ecology
is largely undescribed. Unfortunately, there are a limited number of epidemiologic studies
specifically focusing on Lyme disease occurrence in non-high incidence states. Exploratory
spatial data analyses are particularly suited for public health professionals in these areas
providing baseline risk assessment, and subsequent surveillance initiatives to illustrate spatiotemporal changes in disease occurrence. Further research into the utility of spatial analysis for
public health data is warranted, particularly in non-high incidence states where Lyme disease
occurrence is largely undescribed.
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Figure 1.1 Graphical Representation of Case Classification Criteria from the 2011 Council of State and
Territorial Epidemiologists (CSTE) Lyme disease Case Definition.

** Graphic was obtained from the 2016 West Virginia Bureau of Public Health Lyme disease Case Ascertainment Toolkit.
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Table 1.1 Annual Human Lyme Disease Case Counts within our Multi State Region of
Kentucky, Maryland, Ohio, Pennsylvania, Virginia, and West Virginia, 2010-2014.
State

Population (%)

Case Investigations (%)

Yearly Estimated Incidence
(per 100,000)

2010
6,836
17.1
1,617 (23.7%)
27.9
44 (0.64%)
0.38
3,805 (55.7%)
29.9
1,245 (18.2%)
15.5
125 (1.82%)
6.74
2011
40,096,695
7,924
19.8
Region
Kentucky
5,840,241 (14.6%)
1,351 (17.0%)
23.1
Maryland
11,549,772 (28.8%)
53 (0.67%)
0.46
Ohio
12,741,310 (31.8%)
5,362 (67.7%)
42.1
Pennsylvania
8,110,188 (20.2%)
1,023 (12.9%)
12.6
Virginia
1,855,184 (4.63%)
135 (1.70%)
7.27
West Virginia
2012
44,632,206
7,971
17.9
Region
4,379,730 (9.81%)
14 (0.17%)
0.32
Kentucky
5,884,868 (13.2%)
1,651 (20.7%)
28.1
Maryland
11,553,031 (25.9%)
66 (0.83%)
0.57
Ohio
12,764,475 (28.6%)
5,033 (63.1%)
39.4
Pennsylvania
8,193,422 (18.4%)
1,110 (13.9%)
13.5
Virginia
1,856,680 (4.16%)
97 (1.22%)
5.22
West Virginia
2013
44,793,367
8,685
19.4
Region
4,395,295 (9.81%)
44 (0.51%)
1.00
Kentucky
5,928,814 (13.2%)
1,194 (13.7%)
20.1
Maryland
11,570,808 (25.8%)
93 (1.07%)
0.80
Ohio
12,773,801 (28.5%)
5,904 (68.0%)
46.2
Pennsylvania
8,270,345 (18.5)
1,307 (15.0%)
15.8
Virginia
1,854,304 (4.14%)
143 (1.65%)
7.71
West Virginia
2014
44,531,085
10,387
23.3
Region
4,339,367 (9.74%)
45 (0.43%)
1.03
Kentucky
5,773,552 (13.0%)
1,373 (13.2%)
23.8
Maryland
11,536,504 (25.9%)
119 (1.14%)
1.03
Ohio
12,702,379 (28.5%)
7,487 (72.1%)
58.9
Pennsylvania
8,326,289 (18.7%)
1,346 (13.0%)
16.2
Virginia
1,852,994 (4.16%)
136 (1.31%)
7.34
West Virginia
** Population data are July 1rst mid-year population estimates from each year obtained from the U.S Census
Bureau at the county level.
** Annual Case counts are the sum of the confirmed and probable cases reported by each state’s respective
state level health department. No case investigation data could be gathered from the Kentucky State Department
of Health for 2010 and 2011. As a result population data for Kentucky are also excluded to make our
descriptive analysis as representative of available data within the region as possible.
Region
Kentucky
Maryland
Ohio
Pennsylvania
Virginia
West Virginia

39,922,622
5,787,193 (14.5%)
11,545,435 (28.9%)
12,710,472 (31.8%)
8,025,376 (20.1 )
1,854,146 (4.64%)
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Figure 1.2 Quantile Choropleth Maps Displaying Yearly Crude Incidence by County per
100,000 Persons for Kentucky, Maryland, Ohio, Pennsylvania, Virginia, and West Virginia.
No data are present for Kentucky from 2010-2011, due to data quality issues self-reported by
the Kentucky State Department of Health during data acquisition.
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Figure 1.3 Spatial Empirical Bayesian Smoothed Quantile Choropleth Maps Displaying
Yearly Adjusted Incidence by County per 100,000 Persons for Kentucky, Maryland, Ohio,
Pennsylvania, Virginia, and West Virginia. No data are present for Kentucky from 2010-2011,
due to data quality issues self-reported by the Kentucky State Department of Health during
data acquisition.
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Figure 1.4 Local Indicators of Spatial Autocorrelation (LISA) Cluster Analysis incorporating
rook spatial weight, 99,999 permutations, and a pseudo p-value of 0.05 (Anselin 2003).
Counties in dark grey are “hot spots” or high incidence counties surrounded by high incidence
counties. Light grey counties are “cold spots” or low incidence counties surrounded by other
low incidence counties. Counties in medium grey are statistically significant outliers or low
incidence counties bordered by high incidence counties.
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Figure 1.5 Graphical Representation of the Proportion of County Level Lyme Reporting
Hotspots (High-High), Cold Spots (Low-Low), and Statistically Significant Spatial Outliers
(Low-High) Within the Multistate Region, 2010-2014.
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CHAPTER TWO
Using Exploratory Spatial Data Analysis to Identify and Characterize Patterns of Travel
Associated Confirmed Lyme disease Cases in West Virginia, 2011-2015

ABSTRACT
Travel associated cases of Lyme disease are theorized to have a substantial effect on case
visualization. Yet no study to date has formally focused on identifying the impact of travel
related cases on geographic visualization of Lyme disease occurrence and spread. This study’s
aims were to confirm travel as a source of geographic bias and 2) characterize spatial patterns
associated with the proportion of cases attributable to travel using West Virginia Public health
Lyme disease surveillance data. Confirmed cases were obtained for 2011-2015 from the West
Virginia Bureau of Public Health. Following data preprocessing, variables representing total
overall confirmed cases and only those cases obtaining infection within county of residence were
visualized in separate maps and analyzed using a paired t-test. Spatial autocorrelation was
assessed for the proportion of cases attributable to travel using a Local Moran’s I with empirical
Bayesian rate. The paired t-test indicated statistically significant (t = 3.99, df = 54, P = 0.0002)
non-equivalency between total overall cases and those obtained within patient’s home county.
Local Moran’s I identified statistically significant autocorrelation (I = 0.17, pseudo P = 0.02) and
both clusters and spatial outliers. Findings suggest that travel associated case acquisition is a
significant source of geographic bias in visualization of Lyme disease cases.
Keywords: Travel Associated Case, Lyme disease, Surveillance
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INTRODUCTION
Lyme disease caused by human exposure to the bacterial agent Borrelia burgdorferi, is the most
common vectorborne disease in the United States (1, 2). Human infection results in multisymptom conditions and can lead to serious health consequences if left untreated (3). While
cases have been documented within each state of the contiguous U.S. (4), a proportion are
regarded as travel-associated. The concept of travel associated Lyme disease cases was noted as
early as 1979 (5) and has since been hypothesized as a source of confounding for case
visualization (6, 7). The potential for confounding is exacerbated in low incidence areas where
up to 80% of cases are potentially attributable to recent travel to high incidence areas (8). Yet, no
study to date has confirmed that travel-associated Lyme disease cases is a confounding factor for
spatial analysis within public health surveillance data. Consequently, this retrospective
investigation aims to 1) establish travel as statistically significant source of geographical bias in
visualization of Lyme disease surveillance data and 2) identify spatial patterns in the proportion
of travel related cases reported in West Virginia.
METHODS
Confirmed human Lyme disease case counts for 2011-2015 were provided by the West Virginia
Bureau of Public Health (9). This period was chosen because of similarities in Lyme disease case
definitions, providing consistency among epidemiologic, medical, and laboratory evidence (10).
The data contains variables for the patient’s home county, the reporting year, and a dummy
variable indicating whether a case was travel-related. Criteria used by local health departments to
designate cases as travel related are based upon the patient’s self-reported travel history and most
likely location of tick exposure (11). Three county-level (n=55) variables were created using the
travel-related disease attribute, representing total cases, cases infected within the patient’s home
28

county, and proportion of cases attributable to travel. Spreadsheets were joined in ArcMap
(ESRI, Redlands CA) to a United States Counties and Localities shape file (12). Choropleth
maps were created for total cases and those obtaining infection within their county of residence.
County-level choropleth class breaks were set as 0, 1 to 4, 5 to 20, 21 to 60, and > 60 cases to
place specific emphasis on counties with low to moderate occurrence of Lyme disease (6). A
paired t-test and Wilcoxon Signed Rank test were conducted utilizing SAS 9.4 (SAS Institute,
Cary NC) to determine if the county level differences between total overall confirmed Lyme
disease cases and confirmed cases obtained within patient’s home county were statistically
equivalent to zero. Univariate Local Moran’s I analyses with empirical Bayesian rate were
conducted in GeoDa 1.8 (GeoDa Center, Tempe AZ) to identify spatial patterns, and adjust for
instability of variances in rates calculated (13, 14). A queen’s contiguity matrix was used to
identify neighbors in the local analysis, and results were permuted 99,999 times to detect
statistically significant clustering and outliers at a pseudo p-value of 0.05 (15).
RESULTS
There were 660 confirmed Lyme disease cases in West Virginia from 2011-2015, of which 541
(82%) were obtained within the patient’s home county. Statistically significant non-equivalency
was identified in paired t-test (t = 3.99, df = 54, P = 0.0002) and Wilcoxon Signed Rank test (S =
264, P < 0.001) among variables representing total overall confirmed cases of Lyme disease and
those which obtained infection within their home county. The number of counties within each of
the choropleth classes differed between inclusion or exclusion of travel related cases (Figure
2.1). Univariate Local Moran’s I with empirical Bayesian rate detected statistically significant (I
= 0.17, pseudo P = 0.02) clustering and spatial outliers (Figure 2.2). Counties ranked as highhigh have a high proportion of cases attributable to travel and border counties which on average
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also have a high proportion of travel related cases. Conversely, low-low and low-high counties
have a low proportion of cases attributable to travel which border counties with a low (low-low)
or high (low-high) average proportion of travel related cases.
DISCUSSION
Travel is commonly mentioned as a potential source of bias in Lyme disease literature. West
Virginia is an ideal state to study geographic biases associated with Lyme disease case reporting
as it is a transitional state, bordered on the east by high incidence states of Maryland, Virginia,
and Pennsylvania and on the west by low incidence states of Kentucky and Ohio (16). This is the
first known study to employ statistical and spatial analytic methodologies to confirm the
necessity of adjusting for travel associated cases within public health surveillance data prior to
geographic visualization. Adjustment for travel resulted in statewide changes in the number of
counties represented within each of the choropleth classes (Figure 2.1). In particular, the
choropleth classes with zero, 1 to 4, and 5 to 20 confirmed Lyme disease cases displayed
dramatic (± 16-50%) changes in the percent of counties represented after removing cases that
were attributable to travel. Conversely, exclusion of travel related cases did not result in much
variability (± 1.8%) among the percentage of counties represented within the choropleth classes
of 21 to 60 and > 60 confirmed Lyme disease cases. This suggests that counties that reported a
low number of cases are particularly susceptible to travel related biases. Ultimately, these
changes in the percent of counties within the case based choropleth classes resulted in
visualization of two separate maps which were statistically non-equivalent (t = 3.99, df = 54, P =
0.0002) (Figure 2.1).
Spatial patterns in the proportion of cases attributable to travel were identified utilizing local
indicators of spatial autocorrelation. The cluster map (Figure 2.2) displays significant county30

level clustering in the proportion of cases attributable to travel. The proportion of confirmed
Lyme disease cases attributable to travel by county are provided as a label over LISA results to
provide reference to the crude estimates. Counties in western West Virginia and the Eastern
Panhandle display no significant clustering or clustering of low values of the proportion of cases
attributable to travel. Alternatively, northern and south central West Virginia counties displayed
clustering of high proportions with a few spatial outliers with low values neighboring higher
values. It is important to note that while some counties experienced high proportion of travel
related cases, not all were denoted as high-high in the LISA cluster map. This discrepancy
resulted because the value in a given county was high, but was bordered by neighboring counties
with low proportion of travel related cases (17).
The choropleth maps and patterns of LISA rankings are consistent with previous research
regarding travel biases (8) and highlight potential spatial biases which influence consistency of
non-travel related case reporting due to the combination of low and high incidence states which
share a border with West Virginia (6). This spatial bias may be especially relevant in counties
that form clusters of high proportions of travel-related cases, indicating at-risk areas where Lyme
disease is not yet endemic, although there are enough travel-related cases that the disease may
soon spread to these locations. Future research is warranted to incorporate study findings and
examine other potential geographic biases related to public health surveillance data.
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Figure 2.1 Graphical Representation of the Overall Total and Total Obtained within Patients
Home County Confirmed Human Lyme disease Cases in West Virginia, 2011-2015.
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Figure 2.2 Univariate Local Moran’s I with Empirical Bayesian Rate. Numbers within each of
the counties represent the proportion of confirmed Lyme disease cases attributable to travel.
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CHAPTER THREE
Using Geo-Analytic Techniques to Evaluate the Utility of Companion Animal Tick
Surveillance Practices for Monitoring Spread and Occurrence of Human Lyme disease in
West Virginia, 2014-2016

ABSTRACT
Companion animals such as dogs and cats are potentially effective sentinel populations for
monitoring occurrence and spread of Lyme disease. No study to date has evaluated the public
health utility of sentinel programs using geo-analytic approaches despite the deep-rooted spatial
processes that influence tick-host disease transmission. Confirmed Lyme disease cases in West
Virginia and Ixodes scapularis submitted by veterinarians to the state health department were
obtained for 2014-2016. Separate ordinary least squares and spatial lag regression models were
conducted to estimate the association between average number of Ixodes scapularis collected on
pets and human Lyme disease incidence per 1,000 persons. Residuals from regression models
were visualized using Local Moran’s I as a diagnostic tool to identify spatial dependence among
regression models. Statistically significant associations were identified between average
numbers of Ix. scapularis collected from dogs and human Lyme disease in the OLS (β=0.20 P <
0.001) and spatial lag (β = 0.12, P = 0.002) regression. No significant associations were
identified for cats in either regression model. Statistically significant (P ≤ 0.05) spatial
dependence was identified in all regression models. Local Moran’s I maps produced for spatial
lag regression residuals indicated a decrease in model over and underestimation, but identified a
higher number of statistically significant outliers than OLS regression. Results suggest that dogs
are effective sentinel populations for monitoring human Lyme disease infection. Findings
identify significant spatial effects associated with regression residuals, emphasizing the
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importance of statistical methodologies, which can accommodate the spatial structure of public
health surveillance data.
Keywords: Lyme disease, Surveillance, Spatial Analysis, Companion Animals
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INTRODUCTION
Lyme disease is the most commonly reported vectorborne disease in the United States (1, 2).
Human infection occurs primarily in the Northeastern and North Central United States, but is not
exclusive to these areas due to constant geographic expansion of the principal vector Ixodes
scapularis (3, 4). Human risk of exposure is uncertain in many areas where Lyme disease is
considered an emerging issue due to variability in recognition of infection and disease
manifestation reported by health officials, biases among diagnostic tests, and insensitivity in
local tick surveys at early stage invasion (5-7). Tick surveys among companion animals have
been identified as a potentially representative surveillance methodology for estimating human
risk within geographic areas where Lyme disease is an emerging concern (8). Animals such as
dogs, cats, and horses are potentially effective sentinel populations due to increased likelihood of
tick infestation and close association with their human owners (9). Few studies to date have
evaluated the utility of companion animal sentinel programs as public health tools with spatial
analytic approaches to study the spatial structure of tick-host disease transmission dynamics (10).
Humans and companion animals are dead end hosts for Borrelia burgdorferi, causative agent of
Lyme disease (11, 12). Exposure to tickborne pathogens occurs when a host comes in contact
with actively questing ticks in the environment. Presence of infected ticks are influenced by
environmental factors such as availability of competent reservoir hosts and climatic factors that
drive tick survival and pathogen propagation (13, 14). Domestic pets, such as dogs, are
significant risk factors for disease acquisition, and six times more likely to be exposed to infected
ticks due to the increased potential exposure time in tick habitat (7, 15). Sampling companion
animal populations is an effective approach to estimate human risk in areas where Lyme disease
may be newly endemic.
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Popular concern for Lyme disease has prompted many animal sentinel studies across the United
States and the United Kingdom (6, 7, 16-19). These studies primarily focused on ticks and
associated pathogens collected from domestic dogs because of their ability to produce antibodies
to Borrelia burgdorferi, attainable travel history information, and frequency of outdoor exposure
(6, 11, 20-24). Methodologies for pathogen detection are restricted to serologic tests such as
enzyme-linked immunosorbent assay and Western blot, as well as direct polymerase chain
reaction (PCR) of ticks collected from domestic dogs (6, 7, 16-19). Studies suggest that serology
screening is an effective approach in Lyme endemic areas (25, 26) but may not be as sensitive an
indicator for estimating prevalence of infected ticks as direct screening of ticks via PCR within
areas of low tick density (7). In addition to potential screening biases, previous studies also
suggest variability in sample size by locality may have influenced study findings (19).
Some studies have shown that success in detection of Borrelia burgdorferi in dogs or ticks
collected from dogs correlates with human Lyme disease incidence and tick feeding behavior
within their respective localities (11, 27). This conclusion, along with recognition that tick
survival and disease transmission are spatial processes (13), recommend analytic spatial
approaches to identify areas of increased human risk. To date, no known study has applied
analytic spatial techniques to investigate geographic associations between Ixodes scapularis
collected from sentinel companion animal surveillance and human Lyme disease cases,
investigated sentinel potential for companion animals other than dogs, or employed spatial tools
to identify areas where increased effort may be needed to optimize Lyme disease surveillance
efforts. The objectives of our study are to 1) conduct spatial regression to identify geographic
associations between animal species-specific Ixodes scapularis sentinel and human Lyme disease
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case data and to 2) investigate local clustering of regression residuals to identify counties were
additional effort may be needed to optimize surveillance efficacy.
METHODS
Study Area
Annual confirmed human case counts within West Virginia have increased two-fold between
2005 (n=61) and 2014 (n=136) (3).Geographically, West Virginia is bordered on the east by high
incidence states of Pennsylvania, Maryland, and Virginia and on the west by the low incidence
states of Ohio and Kentucky (CDC 2015). In addition to human cases reported, companion
animal sentinel surveillance data has been collected from local licensed veterinary practices
within the state since 2013 (28).
Data acquisition and management
Human Lyme disease case data in West Virginia were obtained for 2014-2016 from the West
Virginia state health department (29). Human surveillance data were limited to confirmed cases
(based on the 2011 Council of State and Territorial Epidemiologists Lyme disease case
definition) with reported infections acquired within their home county. Restricting raw case
counts limited biases associated with travel related disease acquisition (30), led to consistency of
medical, laboratory, and epidemiologic evidence (31), and included recent exposure to tick
habitat (32). Crude measures of human Lyme disease frequency were calculated by dividing the
sum of 2014-2016 county-level case counts by 2015 U.S. census West Virginia county-level
population estimates (33) to reflect county-level incidence throughout the state from 2014-2016
(34).
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Companion animal surveillance data obtained from the West Virginia state health department
from 2014-2016 and contained yearly county level information relating the diversity and
abundance of different tick species removed from animals by veterinarians participating in the
convenience sample. Sentinel surveillance data requested were limited to 2014-2016, because of
improved data quality following the initial year of data collection. Observations were sorted by
county, and Ixodes scapularis removed from animals were summed across individuals in SAS
9.4.1 (SAS Institute, Cary NC) to produce four variables representing the total and average
number of Ixodes scapularis collected from dogs and cats by county. All licensed veterinary
practices within West Virginia received equal opportunity for voluntary participation. Therefore,
zeros were assigned to any county that had no Ixodes scapularis collection data within our study
period.
Human population and case estimates were paired with average number of Ixodes scapularis
estimates from dogs and cats by respective reporting county in Microsoft Excel. Spreadsheet
were joined in ArcMap 10.4.1 (ESRI Redlands, CA) to a U.S. Counties and Localities shape file
obtained U.S. Department of Agriculture National Resources Conservation Service Geospatial
Gateway (USDA:NRCS) (35).
Regression and Spatial Analysis
Separate ordinary least squares regression models were performed using average number of
Ixodes scapularis collected on dogs and cats as the independent variable and county level human
Lyme disease incidence per 1,000 as the dependent variable. Rook and queen spatial contiguity
weights matrices were visualized within connectivity histograms to characterize neighbor
structures (36). Contiguity based spatial weights were utilized within our spatial analysis to
satisfy regularity conditions and reduce the potential for introducing heteroscedasticity (37). A
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queen contiguity weight was chosen to increase the number of neighbors evaluated during the
spatial analysis (38). Univariate Local Moran’s I and LISA maps were calculated to identify the
extent of spatial autocorrelation within the residuals (39). Lagrange multiplier values were
calculated during the OLS regression utilizing the previously defined queen spatial weights
matrix, as a model selection tool in comparing spatial lag and error regression models (38, 40).
Residuals from the spatial model were visualized using univariate Local Moran’s I LISA maps to
display remaining spatial dependence. Akaike information criterion between OLS and spatial
autoregressive models were compared to examine model goodness of fit. All regression and
spatial analyses were conducted in GeoDa 1.8 (GeoDa Center Tempe, AZ).
RESULTS
Regression and Spatial Analysis
County-level incidence of confirmed human Lyme disease ranged between 0-3.88 per 1,000
persons with an average rate of 0.30 (±0.65) cases per 1,000 persons. County-level Ixodes
scapularis collections ranged from 0-93 for dogs with a mean number removed of 11.2 (±18.8)
and 0-37 for cats with a mean number of 5.6 (±9.30). Ordinary least squares regression
parameters were significant (F = 3.91, P < 0.001) for the dog specific model, and not significant
(F = 0.91, P = 0.36) for the cat specific model. Univariate Local Moran’s I indicated significant
clustering among OLS canine (I = 0.27, pseudo P= 0.002) and cat (I = 0.50, pseudo P < 0.001)
regression residuals. Lagrange multiplier (LM) values were significant for dog spatial lag (F=
24.0, P < 0.01) and dog spatial error (F = 8.19, P = 0.04) as well as cat spatial lag (F= 30.1, P <
0.01) and cat spatial error (F = 27.2, P < 0.001) models. Spatial lag autoregressive model was
chosen based upon higher robust LM values (30.0 vs. 14.0 for dogs and cats (12.8 vs. 9.92) (38),
and because the spatial lag model adjusts for substantive rather than nuisance spatial dependence
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(40). Average number of Ixodes scapularis collected per dog remained significant (F = 3.04, P =
0.002) in the spatial lag model, and identified significant positive spatial dependence (rho = 0.66,
P < 0.001). Average number of Ixodes scapularis collected per cat remained non-significant (F =
-0.01, P =0.88) within the spatial lag model. However, a significant (rho = 0.73, P < 0.001)
strong positive spatial dependence was identified. Univariate Local Moran’s I indicated
significant dispersal among canine (I = -0.14 pseudo P = 0.02) and non-significant dispersal
among feline (I = -0.04 pseudo P =0.40) spatial lag residuals. Parameter estimates for animal
specific regression models are summarized in Table 3.1. Model goodness of fit, measured by a
reduction in Akaike Information Criterion, was improved for dog (AIC = 76.2 vs. AIC = 98.5)
and cat (AIC = 84.5 vs. 111.5) models utilizing spatial lag regression. Local indicators of spatial
autocorrelation (LISA) maps were produced for OLS and spatial lag model residuals for dogs
and cats (Figure 3.1). High-high ranking indicates counties where human Lyme disease cases per
1,000 persons are higher than what would be expected after adjusting for covariates. Conversely,
low, high-low, and low-high rankings indicate counties where human Lyme disease cases per
1,000 are lower, higher surrounded by lower, or lower surrounded by higher than what would be
expected after adjusting for covariates.
DISCUSSION
Exploratory statistical approaches are routinely applied as methods to evaluate associations
between animal sentinel and human disease data. This is the first known study to assess
associations between sentinel surveillance data from dogs and cats and human Lyme disease
incidence utilizing a combination of ordinary least squares and spatial regression models.
Significant associations between Ix. scapularis collections from dogs were identified in OLS and
spatial lag models. This finding is consistent with previous studies which identified dogs as
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potentially effective sentinel animals for monitoring human Lyme disease due to their close
association with pet owners, and increased probability for tick exposure (7, 9, 15). Conversely,
no statistical association was identified between feline Ix. scapularis collections and human
disease in either OLS or spatial lag autoregressive models. While this may seem unexpected due
to the similarities in shared exposure risk between domestic cats and dogs, prevalence and
manifestation of Lyme disease in felines is poorly understood (41).
Further analysis of model residuals via local indicators of spatial autocorrelation permitted
additional insight into surveillance system effectiveness by providing a sound diagnostic
methodology for identifying spatial dependence within the regression models (39, 42). Spatial
dependence, also termed spatial autocorrelation, results when the assumption of independence
among dependent variables is violated, or when the regression residuals themselves display
spatial dependence (42). In either case, parameter estimates from OLS regression are inefficient.
Local indicators of spatial autocorrelation (LISA) (Figure 1) calculated for OLS regression
residuals identified significant clustering of model over and underestimation throughout West
Virginia. Incorporation of the spatial lag model resulted in a reduction in the number of counties
regarded as high-high (model underestimation) and low-low (model overestimation) among dogs
and cats. However, residual spatial dependence was identified within spatial lag model residuals
in the form of low-high and high-low spatial outliers. These spatial outliers are potentially an
artifact of border bias (36), resulting from a shared border with the Lyme disease endemic states
of Pennsylvania, Maryland, and Virginia (1). Additionally, they could also be spurious outliers
resulting from low veterinary participation, and potentially remedied by increasing veterinary
practice recruitment efforts in West Virginia northeastern panhandle counties.
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Study findings are based upon a statewide county level ecological regression between human
Lyme disease incidence per 1,000 persons and animal sentinel data collected as a convenience
sample from 2014-2016. Spatial lag models are often conducted for data aggregated at the
county level, but are potentially prone to ecological fallacy if data incorporated are at differing
spatial scales (37). Additionally, some studies call for the presentation of vector-borne disease
surveillance data at scales finer than the county level (43). We attempt to adjust for ecological
fallacy and misclassification biases by incorporating confirmed cases of human Lyme disease
obtained within patient’s home county of residence and animal sentinel data aggregated at the
same county level scale. Our analysis was limited to county-level scale as this is the finest scale
for which travel-associated infection status is noted. Other potential limitations are associated
with differing reporting biases associated with unequal Lyme disease awareness among
physicians or other public health officials, and varying presentation of Lyme disease signs and
symptoms among patients infected (44-46). Unfortunately, we are unable to characterize the
effect of differing reporting biases due to the aggregate nature of our retrospective investigation.
Despite these limitations, findings fill significant gaps in the literature regarding the spatial
biases of public health surveillance data. Results confirm the efficacy of companion animal
sentinel surveillance programs by further implicating dogs as risk factors for human Lyme
disease infection. Interestingly, residual spatial dependence was identified among spatial models
and potentially point to other geographic biases not considered. In particular, West Virginia is
prone to border biases resulting from shared boundaries with both high and low incidence states
(1, 36). Results highlight the unique geographic position that West Virginia shares with its
neighboring states, and emphasize the necessity of spatial analysis to adjust for inherent biases
associated with collection of public health surveillance data.
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Table 3.1 Summary of Animal Species Specific Regression Results
Variable
Estimate
Dog Specific Regression Models
Model 1: Ordinary Least Squares Regression
Average Ix. scapularis collected
0.20
Model 2: Spatial Lag Regression
Average Ix. scapularis collected
0.12
Average Incidence per 1,000 Persons of Neighboring Counties
0.66
Cat Specific Regression Models
Model 1: Ordinary Least Squares Regression
Average Ix. scapularis collected
0.07
Model 2: Spatial Lag Regression
Average Ix. scapularis collected
-0.01
Average Incidence per 1,000 Persons of Neighboring Counties
0.73

Std. Error

P-Value

0.06

< 0.001

0.04
0.10

0.002
< 0.001

0.08

0.36

0.55
0.09

0.88
< 0.001

48

Figure 3.1 Local indicators of spatial autocorrelation maps output from univariate Local
Moran’s I for dog and cat Ordinary Least Squares and Spatial Lag Regression Residuals
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PROJECT CONCLUSIONS
Mapping of surveillance data has become an increasingly popular method for relaying public
health information due to the wide availability of geographic information systems. Approaches
such as disease mapping and cluster analysis have proven useful in public health practice,
particularly in reference to vectorborne disease (1, 2). Despite the recognition of place in human
transmission cycles of vectorborne diseases, many studies have yet to characterize geographic
biases affecting accurate representation of human cases. Our series of three studies were the first
to identify the effects of boundary and travel related biases on human incidence of Lyme disease
using ESDA approaches. We then adjust for these biases to increase accuracy of our regression
models used to investigate associations between companion animal sentinel surveillance
programs and human Lyme disease incidence. Together the results from these three studies close
gaps in current knowledge surrounding accurate representation of surveillance data and provide
the first account of ESDA techniques used to characterize occurrence of human Lyme disease in
Kentucky, Ohio, and West Virginia.
Each of our studies were based upon investigation classes within spatial epidemiology with
careful consideration of cartographic principles to avoid misrepresenting mapped information.
Our first two investigations were an exercise in disease mapping and cluster analysis, while the
third was consistent with an ecological analysis. It is important to note that while crude disease
mapping and cluster analysis are useful in identifying patterns of disease intensity, they lack the
ability to explain observed patterns (3). Therefore, approaches such as stratification and
traditional confirmatory statistics were paired with ESDA techniques to provide further
processing and complementary statistical information to avoid misrepresenting mapped
information (4). Additionally, identical semiotic displays were employed utilizing the same
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predefined classes and color schemes to represent LISA cluster map results. Scale for each of the
studies was limited to the county level because of data availability. While some studies have
criticized representation of surveillance information at scales as low as the county level (5), data
on relevant potential confounders were collected no finer than the county-level.
Even with careful consideration of cartographic principles and pairing of statistical
methodologies, it is important to note limitations to the project. Findings were based upon
multiple exploratory spatial analyses of passively collected surveillance data. Therefore, results
are potentially prone to misclassification bias stemming from inconsistent reporting influenced
by varying presentation of patient signs and symptoms as well as unequal Lyme disease
awareness (6-8). Additionally, the decision to designate a case as travel related was based upon
self-reported travel history and most likely location for exposure. All of these are potentially
prone to recall bias. Other important considerations are linked to volunteer biases potentially
influencing the number of veterinary practices participating by county in the companion animal
surveillance program (9). Unfortunately, we were unable to control for many of these
information and selection biases due to the retrospective nature of our investigations.
Despite these limitations, ESDA tools and public health surveillance data offer a practical and
efficient means to monitor occurrence and spread of disease (10). Overall, project findings:
1) Indicate a significant increasing time trend in the identification of high-high counties
of Lyme disease in Maryland, Pennsylvania, Virginia, and West Virginia
2) Confirm travel associated case inclusion as a confounder of accurate representation of
mapped Lyme disease surveillance data
3) Demonstrate the effectiveness of spatial regression models to evaluate the efficacy of
animal sentinel programs in predicting occurrence of human Lyme disease.
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These conclusions are consistent with previous research at the state and national level that
observed Lyme disease cases clusters at state lines, and hypothesized this to result from
disproportionate presence of infected ticks, and human behaviors such as travel (3, 11-16). Most
notably, our findings support previous statements regarding the continually ongoing geographic
expansion of high-risk Lyme disease designation (10). Future research is warranted to examine
the extent of geographic influence other potential confounding variables have in accurate
visualization of human Lyme disease incidence. Additionally, further research is critical to
understanding the effect of increasing number of collection localities on spatial model efficiency
for estimating associations between sentinel tick collection methodologies and human Lyme
disease incidence.

52

LITERATURE CITED
1.
2.
3.

4.
5.
6.
7.
8.
9.

10.
11.

12.

13.

14.
15.
16.

Jacquez G. Spatial analysis in epidemiology: Nascent science or a failure of GIS? J
Geography Sys 2000;2:91-7.
Killilea M, Swei A, Lane R, et al. Spatial Dynamics of Lyme Disease: A Review.
EcoHealth 2008;5:167-95.
Szonyi B, Srinath I, Esteve-Gassent M, et al. Exploratory spatial analysis of Lyme
disease in Texas -what can we learn from the reported cases? BMC Public Health
2015;15(924):1-8.
Lawson AB. Statistical Methods in Spatial Epidemiology. Chichester, NY: Wiley & Sons
Ltd.; 2013.
Eisen L. ER. Need for Improved Methods to Collect and Present Spatial Epidemiologic
Data for Vectorborne Diseases. Emerging Infectious Diseases 2007;13(12):1816-20.
Hayes E, Piesman J. How Can We Prevent Lyme Disease. The New England Journal of
Medicine 2003;348:2424-30.
Bacon R, Kugeler K, Mead P. Surveillance for Lyme Disease --- United States, 1992-2006. MMWR 2008;57(SS10):1-9.
Brett M, Hinckley A, Zielinski-Gutierrez E, et al. U.S. healthcare providers' experience
with Lyme and other tick-borne diseases. Ticks and Tick-borne Diseases 2014;5:404-8.
Johnson JL., Ginsberg HS., Zhioua E., et al. Passive Tick Surveillence, Dog
Seropositivity, and Incidence of Human Lyme disease. Vector-Borne and Zoonotic
Diseases 2004;4(2):137-42.
Kugeler KJ., Farley GM., Forrester JD., et al. Geographic Distribution and Expansion of
Human Lyme Disease, United States. Emerging Infectious Diseases 2015;21(8):1455-57.
Bunnell J, Price S, Das A, et al. Geographic Information Systems and Spatial Analysis of
Adult Ixodes scapularis (Acari: Ixodidae) in the Middle Atlantic Region of the U.S.A.
Journal of Medical Entomology 2003;40(4):570-76.
Eisen R, Lane R, Fritz C, et al. Spatial Patterns of Lyme Disease Risk in California Based
On Disease Incidence Data and Modeling of Vector-Tick Exposure. American Journal of
Tropical Medicine and Hygiene 2006;75(4):669-76.
Glavanakov S, White D, Caraco T, et al. Lyme Disease in New York State: Spatial
Pattern at a Regional Scale. American Journal of Tropical Medicine and Hygiene
2001;65(5):538-45.
Li J, Hong K, Duan Y, et al. Spatial and Temporal Emergence Pattern of Lyme Disease
in Virginia. American Journal Tropical Medicine and Hygiene 2014;91(6):1166-72.
Brinkerhoff J, Gilliam W, Daines D. Lyme Disease, Virginia, USA, 2000-2011.
Emerging Infectious Diseases 2015;20(10):1661-68.
Xue L, Scoglio C, McVey S, et al. Two Introductions of Lyme Disease into Connecticut:
A Geospatial Analysis of Human Cases from 1984 to 2012. 2015:523-28.

53

